WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc EUR is a equity ETF from WisdomTree tracking the US Quality Dividend Growth index through physical replication. Domiciled in Ireland and launched in 2016, the fund manages about 593 M € and charges a TER of 0.33% — 33 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc EUR competes with 1 other products on the same index (US Quality Dividend Growth): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.33% against a group median of 0.33%. It has been listed since 2016, 10 years of track record.
On a €10,000 investment the TER costs 33 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 38.8% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in USD. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| Microsoft Corporation | 5.9% |
| Apple Inc. | 5.3% |
| NVIDIA Corporation | 4.4% |
| Exxon Mobil Corp | 4.3% |
| Broadcom Inc | 3.7% |
| AbbVie Inc | 3.6% |
| UnitedHealth Group Incorporated | 3.0% |
| The Coca-Cola Company | 3.0% |
| The Home Depot Inc | 2.9% |
| Merck & Company Inc | 2.7% |
| Borsa Italiana | DGRA | EUR |
| XETRA | WTDM | EUR |
| London Stock Exchange | DGRG | GBX |
| London Stock Exchange | DGRA | USD |
| Euronext Paris | DGRA | EUR |
| SIX Swiss Exchange | DGRA | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.